Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 18 Neoplasms 9 Colonic Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Breast Neoplasms 6 Uterine Cervical Neoplasms 4 Colorectal Neoplasms 4 Uterine Cervical Dysplasia 3 Urinary Bladder Neoplasms 3 Mouth Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Hepatocellular 3 Thyroid Nodule 2 Thyroid Neoplasms 2 Thrombocythemia, Essential 2 Testicular Neoplasms 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycythemia Vera 2 Oropharyngeal Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Liver Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Hodgkin Disease 2 Glioma 2 Gallbladder Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Basal Cell 2

Interventions

Cyclophosphamide 160 Rituximab 82 Peripheral Blood Stem Cell Transplantation 78 fludarabine phosphate 75 Etoposide 69 Filgrastim 67 Methotrexate 59 Cytarabine 58 Vincristine 50 Mycophenolic Acid 50 Whole-Body Irradiation 48 Radiotherapy 43 Cyclosporine 43 Busulfan 42 Tacrolimus 40 Melphalan 39 Dexamethasone 37 Prednisone 36 Doxorubicin 36 Antilymphocyte Serum 36 fludarabine 31 blinatumomab 27 Methylprednisolone 24 Granulocyte Colony-Stimulating Factor 22 Carmustine 22 Cord Blood Stem Cell Transplantation 21 Calcium Dobesilate 18 CT-P10 18 Inotuzumab Ozogamicin 16 sargramostim 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Burkitt Lymphoma × Watchful Waiting × Clear all

NCT04425421 2026-03-02

GFALMB2019

French Africa Pediatric Oncology Group

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡